Trials / Completed
CompletedNCT03864458
Dose-finding Study of KHK7791 in Hyperphosphatemia Patients
A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-finding Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 207 (actual)
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effect and safety of KHK7791 to treat Hyperphosphatemia in ptatients on HD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KHK7791 | oral administration |
| DRUG | Placebo | oral administration |
Timeline
- Start date
- 2019-04-15
- Primary completion
- 2019-12-10
- Completion
- 2019-12-31
- First posted
- 2019-03-06
- Last updated
- 2024-03-07
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03864458. Inclusion in this directory is not an endorsement.